+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
JORVEZA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JORVEZA Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Metronidazole Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Metronidazole Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
Ulcerative Colitis (UC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ulcerative Colitis (UC) - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 147 Pages
  • Global
From
US VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

US VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • United States
From
From
Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chemotherapy Induced Diarrhea - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 60 Pages
  • Global
From
REMICADE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
AJM300 Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AJM300 Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
ENTYVIO Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENTYVIO Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
REMICADE Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
XENICAL (Orlistat), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

XENICAL (Orlistat), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
ENTYVIO (Vedolizumab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENTYVIO (Vedolizumab) Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Ascites - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ascites - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more